Primary Site >> Colorectal Cancer
Gene >> SEPT9
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: DNA methylation biomarkers for blood-based colorectal cancer screening. PMID: 18089654 Ref: Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PMID: 19018278 |
Ref: Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. PMID: 19406918 Ref: [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker]. PMID: 19443305 |
Ref: Performance of epigenetic markers SEPT9 and ALX4 in plasma for detection of colorectal precancerous lesions. PMID: 20140221 Ref: Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. PMID: 20407014 Ref: Recent patents and advances in genomic biomarker discovery for colorectal cancers. PMID: 20426761 Ref: A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation. PMID: 20525169 Ref: [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer]. PMID: 20552891 Ref: Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. PMID: 20804913 Ref: From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood. PMID: 22121975 |
Ref: The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer. PMID: 21267688 Ref: Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. PMID: 21326223 Ref: Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. PMID: 22168215 |
Ref: Review of biomarkers in colorectal cancer. PMID: 21040359 Ref: The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia. PMID: 22019796 Ref: Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays. PMID: 22552777 Ref: Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers. PMID: 23049919 Ref: A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors. PMID: 23324654 |
Ref: DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer. PMID: 23694962 Ref: Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. PMID: 23730408 Ref: Colorectal cancer screening with blood-based biomarkers: cost-effectiveness of methylated septin 9 DNA versus current strategies. PMID: 23796793 Ref: Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study. PMID: 23862763 Ref: Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island. PMID: 23988185 Ref: DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer. PMID: 24057814 Ref: [The new blood test bio-marker SEPT9 and colorectal carcinoma screening]. PMID: 24279440 |
Ref: Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. PMID: 23408352 Ref: Blood-based testing for colorectal cancer screening. PMID: 24307563 Ref: A panel of genes methylated with high frequency in colorectal cancer. PMID: 24485021 Ref: High methylation of the SEPT9 gene in Chinese colorectal cancer patients. PMID: 24535900 Ref: Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report. PMID: 24633736 Ref: Preferences for blood-based colon cancer screening differ by race/ethnicity. PMID: 24636031 Ref: Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer. PMID: 24925595 Ref: Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. PMID: 24938752 Ref: Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future. PMID: 25123042 Ref: IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer. PMID: 25127039 Ref: Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. PMID: 25526039 Ref: [Significance of Septin9 gene methylation detection of plasma circulation DNA in colorectal cancer screening]. PMID: 25623318 Ref: Molecular Diagnostic Applications in Colorectal Cancer. PMID: 27600342 |
Ref: Plasma methylated septin 9: a colorectal cancer screening marker. PMID: 25429690 Ref: Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. PMID: 25471329 Ref: WITHDRAWN: SEPT9 DNA methylation as an early diagnostic marker in colorectal cancer. PMID: 25908231 Ref: Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer. PMID: 25946211 Ref: Methylation of cell-free circulating DNA in the diagnosis of cancer. PMID: 25988180 Ref: SEPT9: A Specific Circulating Biomarker for Colorectal Cancer. PMID: 26471083 Ref: Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study. PMID: 26514170 Ref: Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker. PMID: 26633373 |
Ref: Early detection of colorectal cancer: from conventional methods to novel biomarkers. PMID: 25687380 Ref: Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review. PMID: 26998585 Ref: Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening. PMID: 27133379 Ref: Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review. PMID: 27158984 Ref: Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. PMID: 27304597 Ref: DNA methylation based biomarkers in colorectal cancer: A systematic review. PMID: 27385266 Ref: PMID: 27441328 Ref: Discovery and Validation of Hypermethylated Markers for Colorectal Cancer. PMID: 27493446 Ref: Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer. PMID: 27566576 Ref: SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas. PMID: 27660666 Ref: Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. PMID: 27895817 Ref: Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker. PMID: 28105243 |
Ref: The Relationship between the Methylated Septin-9 DNA Blood Test and Stool Occult Blood Test for Diagnosing Colorectal Cancer in Taiwanese People. PMID: 27390118 Ref: Acute myocardial infarction or stroke in occult colorectal cancer: Epiphenomena of the degree of epigenetic deregulation of SEPT9 gene? PMID: 27838469 Ref: Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients. PMID: 28035516 Ref: Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis. PMID: 28102859 Ref: A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis. PMID: 28128742 Ref: The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location. PMID: 28224298 Ref: The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening. PMID: 28470092 Ref: The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis. PMID: 28596563 Ref: Hypermethylated DNA, a circulating biomarker for colorectal cancer detection. PMID: 28700744 Ref: A pooled analysis of the diagnostic efficacy of plasmic methylated septin-9 as a novel biomarker for colorectal cancer. PMID: 29085631 |
Ref: Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection. PMID: 29375744 Ref: A robust internal control for high-precision DNA methylation analyses by droplet digital PCR. PMID: 29484034 Ref: A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway. PMID: 29486770 Ref: Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study. PMID: 29610456 Ref: Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum. PMID: 29614786 Ref: Cell-Free Circulating Methylated SEPT9 for Noninvasive Diagnosis and Monitoring of Colorectal Cancer. PMID: 29849824 Ref: Genome wide DNA differential methylation regions in colorectal cancer patients in relation to blood related family members, obese and non-obese controls - a preliminary report. PMID: 29876008 Ref: Systematic review of blood diagnostic markers in colorectal cancer. PMID: 30022330 Ref: The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer. PMID: 30043648 Ref: Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis. PMID: 30080722 Ref: Discrimination of methylated and nonmethylated region of a colorectal cancer related promoter using fluorescence enhancement of gold nanocluster at intrastrand of a 9C-loop. PMID: 30215606 Ref: The Pathological Features of Colorectal Cancer Determine the Detection Performance on Blood ctDNA. PMID: 30223720 Ref: Detection of Methylated SEPT9 in Korean Colorectal Cancer Patients: Comparison with Previous Studies. PMID: 30273999 Ref: Fluorescence enhancement of silver nanocluster at intrastrand of a 12C-loop in presence of methylated region of sept 9 promoter. PMID: 30278898 |